Novartis loses initial bid to block generic of best-selling heart drug
Novartis failed to persuade a federal court to bar generics maker MSN Pharmaceuticals from marketing its own version of Entresto, Novartis’ favoured drug, according to a court ruling on Monday.
ENTRADAS POPULARES
UK sets new climate target for 2035
noviembre 13, 2024
Children go back to school after Valencia floods
noviembre 13, 2024
Researchers document huge decline in African elephants
noviembre 13, 2024
Mission: Impossible 8 title revealed
noviembre 13, 2024
TRANSMISIÓN EN VIVO